diabetes

FDA Grants AppliedVR Breakthrough Designation for Virtual Reality Chronic Pain Treatment

  • by

What You Should Know: – FDA awards AppliedVR Breakthrough Device designation for treating treatment-resistant fibromyalgia and chronic intractable lower back pain – AppliedVR’s EaseVRx program helps patients learn self-management skills grounded in evidence-based cognitive-behavioral therapy (CBT) principles and other behavioral methods. AppliedVR, a pioneer advancing… Read More »FDA Grants AppliedVR Breakthrough Designation for Virtual Reality Chronic Pain Treatment

Sharing rebates can improve access to medicines and increase health equity

  • by

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we… Read More »Sharing rebates can improve access to medicines and increase health equity

Innovaccer, CareSignal Partner to Enable Deviceless Remote Patient Monitoring

  • by

What You Should Know: – Innovaccer has recently partnered with CareSignal to address healthcare’s urgent need amidst the COVID-19 pandemic: to create and maintain solid, clinically actionable relationships with patients in a new set of predominantly virtual care. – CareSignal offers evidence-based end-to-end support services… Read More »Innovaccer, CareSignal Partner to Enable Deviceless Remote Patient Monitoring

Eli Lilly Reports Results of Jardiance (empagliflozin) in P-III EMPEROR Trial for Heart Failure Patients with Reduced Ejection Fraction with and without Diabetes

  • by

Shots: The P-III EMPEROR Trial involves assessing of Jardiance (10 mg) vs PBO in two studies EMPEROR-Reduced [NCT03057977, N=3,730] & EMPEROR-Preserved [NCT03057951, N=5,990] in patients with HFrEF & HFpEF respectively The EMPEROR-Reduced study meets its 1EPs in reducing the risk for the composite of cardiovascular… Read More »Eli Lilly Reports Results of Jardiance (empagliflozin) in P-III EMPEROR Trial for Heart Failure Patients with Reduced Ejection Fraction with and without Diabetes

Trial shows AZ’s Farxiga slows onset of chronic kidney disease and cuts mortality

  • by

AstraZeneca’s Farxiga could be on course for another use, after trial results showed it slowed the worsening of renal function and cut the risk of death in patients with chronic kidney disease with and without type 2 diabetes. Farxiga (dapagliflozin), an oral once-daily sodium-glucose co-transporter-2… Read More »Trial shows AZ’s Farxiga slows onset of chronic kidney disease and cuts mortality

DarioHealth, Williams Medical Partner to Expand Digital Therapeutics Platform Across the UK and Ireland

  • by

What You Should Know: – Dario Health enters strategic partnership with Williams Medical marking its expansion into the UK remote patient monitoring market across the UK and Ireland. – Williams Medical is the leading provider of medical goods and services to primary care in the… Read More »DarioHealth, Williams Medical Partner to Expand Digital Therapeutics Platform Across the UK and Ireland

New CVS Pharmacy App Feature Can Read Prescription Labels Out Loud for Visually Impaired

What You Should Know: – CVS introduced Spoken Rx™, a new feature of the CVS Pharmacy app that can read important prescription information out loud. It is vitally important for patient safety and adherence that prescription labels are clear and visible, but for patients with visual impairments… Read More »New CVS Pharmacy App Feature Can Read Prescription Labels Out Loud for Visually Impaired

Philips and BioIntelliSense Integrate to Enhance Remote Patient Monitoring

What You Should Know: – Philips integrates the BioIntelliSense FDA-cleared BioSticker™ sensor as part of its remote patient monitoring solutions for patients outside the hospital. – Multi-parameter sensors aid monitoring across multiple chronic conditions with medical-grade vital signs for physicians to remotely track core symptoms,… Read More »Philips and BioIntelliSense Integrate to Enhance Remote Patient Monitoring